Why The World Still Needs Innovative COVID-19 Solutions Beyond Vaccines forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Playback singer Shaswat Singh
The lead voice of AR Rahman’s recently-released 99 Songs, Shashwat Singh on the lessons he learnt from the maestro
When AR Rahman wanted to check his voice out, nervousness got the better of Shashwat Singh and he messed it up.
The maestro asked him to try again. This time, his rendition of ‘You Raise Me Up’ won him appreciation, and a call from Rahman’s office to record ‘Wat Wat’ for the Hindi film
Tamasha (2015) a month later.
After
Mohenja Daro and ‘Ruby Ruby’ for
Sanju in 2018 – all Rahman’s compositions
Five years after
Tamasha, Shashwat’s five tracks from the recently-released Hindi film
Share this article
Share this article
SAN CARLOS, Calif., Feb. 16, 2021 /PRNewswire/ CAGE Bio Inc., an innovative biotechnology company focused on developing innovative therapies for infection, inflammation and immunology, announced the closing of a $7.2 million over-subscribed Series A financing. The investment was led by professional and angel investor groups consisting of current and former pharmaceutical executives and physicians.
CAGE Bio s mission is to translate ionic liquids into transformational consumer healthcare and prescription therapeutics. The financing will enable CAGE Bio to strengthen the team, launch consumer healthcare products, and advance their lead therapeutic product for papulopustular rosacea to phase 2. The support of investors with proven track records in the healthcare space is validation of the therapeutic benefits and disruptive potential of ionic liquids, said Nitin Joshi, co-founder and chief executive officer, CAGE Bio. We are exc
Indore News Install rain water harvesting system in civilian homes naidunia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naidunia.com Daily Mail and Mail on Sunday newspapers.
New Nanoparticle Platform Could Help Treat Various Neurological Disorders
Written by AZoNanoJan 4 2021
Over the last few decades, scientists have established the biological pathways that cause neurodegenerative diseases and have created potential molecular agents to target these pathways.
Yet, there has been a delay in translating these discoveries into clinically approved treatments, partially due to the challenges faced by researchers in delivering therapeutics into the brain through the blood-brain barrier (BBB).
To enable the successful delivery of therapeutic agents into the brain, a group of physicians, bioengineers, and colleagues from Brigham and Women’s Hospital and Boston Children’s Hospital developed a nanoparticle platform with the ability to facilitate therapeutically efficacious delivery of encapsulated agents in mice with an intact or physically breached BBB.